Metabolic syndrome, haemostasis and thrombosis

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Thrombosis and Haemostasis

• Publication date

  2008-05-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1160/TH07-11-0682PMID 18521499
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardiovascular Risk Factors and Venous Thromboembolism: A Meta-Analysis

  2008cited by this paper
• Heritability of Clot Formation, Morphology, and Lysis: The EuroCLOT Study

  2007cited by this paper
• Links between arterial and venous disease

  2007cited by this paper
• No functional role of plasminogen activator inhibitor‐1 in murine adipogenesis or adipocyte differentiation

  2007cited by this paper
• Randomized Comparison of a High Clopidogrel Maintenance Dose in Patients With Diabetes Mellitus and Coronary Artery Disease: Results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) Study

  2007cited by this paper
• Multimarker Approach to Evaluate the Incidence of the Metabolic Syndrome and Longitudinal Changes in Metabolic Risk Factors: The Framingham Offspring Study

  2007cited by this paper
• Atherothrombosis: role of tissue factor; link between diabetes, obesity and inflammation.

  2007cited by this paper
• Leptin induces tissue factor expression in human peripheral blood mononuclear cells: a possible link between obesity and cardiovascular risk?

  2007cited by this paper
• Endothelin Limits Insulin Action in Obese/Insulin-Resistant Humans

  2007cited by this paper
• AHA/ADA vs. ESC/EASD recommendations on aspirin as a primary prevention strategy in people with diabetes: how the same data generate divergent conclusions.

  2007cited by this paper
• Endothelial dysfunction is related to insulin resistance and inflammatory biomarker levels in obese prepubertal children.

  2007cited by this paper
• Do inflammation and procoagulation biomarkers contribute to the metabolic syndrome cluster?

  2007cited by this paper
• Diabetes mellitus as a prothrombotic condition

  2007cited by this paper
• Adiponectin, ghrelin, and leptin differentially influence human platelet and human vascular endothelial cell functions: implication in obesity-associated cardiovascular diseases.

  2007cited by this paper
• The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspectives.

  2007cited by this paper
• Venous thromboembolism in association with features of the metabolic syndrome.

  2007cited by this paper
• PAI-1 and the Metabolic Syndrome: Links, Causes, and Consequences

  2006cited by this paper
• Modulation of Adipose Tissue Development by Pharmacological Inhibition of PAI-1

  2006cited by this paper
• Adiponectin Acts as an Endogenous Antithrombotic Factor

  2006cited by this paper
• Endothelial and antithrombotic actions of HDL.

  2006cited by this paper
• Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction: Molecular and Pathophysiological Mechanisms

  2006cited by this paper
• Plasminogen activator inhibitor-1 modulates adipocyte differentiation.

  2006cited by this paper
• Progression of Plasminogen Activator Inhibitor-1 and Fibrinogen Levels in Relation to Incident Type 2 Diabetes

  2006cited by this paper
• Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study.

  2006cited by this paper
• Altered Fibrin Architecture Is Associated With Hypofibrinolysis and Premature Coronary Atherothrombosis

  2006cited by this paper
• Venous thromboembolism--a manifestation of the metabolic syndrome.

  2006cited by this paper
• The aetiology of deep venous thrombosis.

  2006cited by this paper
• Platelet resistance to the anti-aggregating agents in the insulin resistant states.

  2006cited by this paper
• Tiplaxtinin impairs nutritionally induced obesity in mice

  2006cited by this paper
• The metabolic syndrome and the risk of venous thrombosis: a case–control study

  2006cited by this paper
• Pathophysiology of platelet resistance to anti-aggregating agents in insulin resistance and type 2 diabetes: implications for anti-aggregating therapy.

  2006cited by this paper
• Adipocytokines and incident diabetes mellitus in older adults: the independent effect of plasminogen activator inhibitor 1.

  2006cited by this paper
• Leptin and atherosclerosis.

  2006cited by this paper
• Effects of hyperglycemia and hyperinsulinemia on circulating tissue factor procoagulant activity and platelet CD40 ligand.

  2006cited by this paper
• PAI-1 inhibition in obesity and the metabolic syndrome: A promising therapeutic strategy

  2006cited by this paper
• Platelet Activation by Low Density Lipoprotein and High Density Lipoprotein

  2006cited by this paper
• Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome.

  2006cited by this paper
• Insulin resistance as a determinant of platelet activation in obese women.

  2006cited by this paper
• Bone Marrow Plasminogen Activator Inhibitor-1 Influences the Development of Obesity*

  2006cited by this paper
• Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome

  2006cited by this paper
• Tumor Necrosis Factor- (cid:1) Induces Endothelial Dysfunction in the Prediabetic Metabolic Syndrome

  2006cited by this paper
• Activation of Platelet Function Through G Protein–Coupled Receptors Platelets as Immune Cells: Bridging Inflammation and Cardiovascular Disease In Vivo Thrombus Formation Platelet Adhesion Platelet Inhibitors and Thrombus Formation

  2006cited by this paper
• Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment.

  2005cited by this paper
• The leptin receptor system of human platelets

  2005cited by this paper
• Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.

  2005cited by this paper
• High-Density Lipoprotein Deficiency and Dyslipoproteinemia Associated With Venous Thrombosis in Men

  2005cited by this paper
• Effects of physiological leptin administration on markers of inflammation, platelet activation, and platelet aggregation during caloric deprivation.

  2005cited by this paper
• Platelet Inhibition by Insulin Is Absent in Type 2 Diabetes Mellitus

  2005cited by this paper
• On the role of plasminogen activator inhibitor‐1 in adipose tissue development and insulin resistance in mice

  2005cited by this paper
• Hemostatic risk factors and insulin sensitivity, regional body fat distribution, and the metabolic syndrome.

  2005cited by this paper
• Serum Lipid Levels and the Risk of Venous Thrombosis

  2004cited by this paper
• Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1.

  2004cited by this paper
• Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women.

  2004cited by this paper
• Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans.

  2004cited by this paper
• Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition

  2004cited by this paper
• Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition

  2004cited by this paper
• Nutritionally Induced Obesity Is Attenuated in Transgenic Mice Overexpressing Plasminogen Activator Inhibitor-1

  2003cited by this paper
• Plasminogen activator inhibitor type-1 inhibits insulin signaling by competing with alphavbeta3 integrin for vitronectin binding.

  2003cited by this paper
• Obesity is associated with impaired platelet-inhibitory effect of acetylsalicylic acid in nondiabetic subjects

  2003cited by this paper
• Leptin-dependent platelet aggregation in healthy, overweight and obese subjects

  2003cited by this paper
• A novel role for CD36 in VLDL-enhanced platelet activation.

  2003cited by this paper
• Plasma PAI-1 Levels Are More Strongly Related to Liver Steatosis Than to Adipose Tissue Accumulation

  2003cited by this paper
• Plasminogen activator inhibitor type‐1 inhibits insulin signaling by competing with αvβ3 integrin for vitronectin binding

  2003cited by this paper
• The concentrations of soluble vascular cell adhesion molecule-1 and lipids are independently associated with venous thromboembolism.

  2003cited by this paper
• Insulin resistance: an atherothrombotic syndrome

  2003cited by this paper
• Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies.

  2003cited by this paper
• Reduction of Inflammatory Cytokine Concentrations and Improvement of Endothelial Functions in Obese Women After Weight Loss Over One Year

  2002cited by this paper
• Influence of insulin and of insulin resistance on platelet and vascular smooth muscle cell function.

  2002cited by this paper
• Stromal Cells Are the Main Plasminogen Activator Inhibitor‐1‐Producing Cells in Human Fat: Evidence of Differences Between Visceral and Subcutaneous Deposits

  2002cited by this paper
• Relationship between obesity, insulin resistance, and coronary heart disease risk.

  2002cited by this paper
• Inhibition of Platelet‐Collagen Interaction An In Vivo Action of Insulin Abolished by Insulin Resistance in Obesity

  2002cited by this paper
• Platelet activation in obese women: role of inflammation and oxidant stress.

  2002cited by this paper
• The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.

  2002cited by this paper
• Age-Dependent Spontaneous Coronary Arterial Thrombosis in Transgenic Mice That Express a Stable Form of Human Plasminogen Activator Inhibitor-1

  2002cited by this paper
• Hyperlipidaemia and venous thromboembolism in patients lacking thrombophilic risk factors

  2002cited by this paper
• Inhibition of Phosphatidylinositol 3-Kinase Enhances Mitogenic Actions of Insulin in Endothelial Cells*

  2002cited by this paper
• Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.

  2002cited by this paper
• Elevated Numbers of Tissue-Factor Exposing Microparticles Correlate With Components of the Metabolic Syndrome in Uncomplicated Type 2 Diabetes Mellitus

  2002cited by this paper
• Disruption of the plasminogen activator inhibitor‐1 gene reduces the adiposity and improves the metabolic profile of genetically obese and diabetic ob/ob mice

  2001cited by this paper
• The Prothrombotic Effects of Leptin

  2001cited by this paper
• Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity.

  2001cited by this paper
• Leptin does not play a major role in platelet aggregation in obesity and leptin deficiency.

  2001cited by this paper
• The prothrombotic effects of leptin possible implications for the risk of cardiovascular disease in obesity.

  2001cited by this paper
• Regulation of tissue factor gene expression in obesity.

  2001cited by this paper
• Physiologic hyperinsulinemia enhances human skeletal muscle perfusion by capillary recruitment.

  2001cited by this paper
• Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study.

  2000cited by this paper
• Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome.

  2000cited by this paper
• Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

  2000cited by this paper
• Interaction between insulin sensitivity and muscle perfusion on glucose uptake in human skeletal muscle: evidence for capillary recruitment.

  2000cited by this paper
• Cell Adhesion and Focal Adhesion Kinase Regulate Insulin Receptor Substrate-1 Expression*

  2000cited by this paper
• Increased plasminogen activator inhibitor-1 and vasculopathy. A reconcilable paradox.

  1999cited by this paper
• Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: "the study of men born in 1913".

  1999cited by this paper
• Leptin promotes aggregation of human platelets via the long form of its receptor.

  1999cited by this paper
• PAI-1 produced ex vivo by human adipose tissue is relevant to PAI-1 blood level.

  1999cited by this paper
• Insulin, insulin resistance and platelet function: similarities with insulin effects on cultured vascular smooth muscle cells

  1998cited by this paper
• Tissue factor gene expression in the adipose tissues of obese mice.

  1998cited by this paper
• Production of Plasminogen Activator Inhibitor 1 by Human Adipose Tissue: Possible Link Between Visceral Fat Accumulation and Vascular Disease

  1997cited by this paper
• Leptin concentrations and insulin sensitivity in normoglycemic men

  1997cited by this paper
• Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities.

  1996cited by this paper
• Enhanced expression of PAI–1 in visceral fat: Possible contributor to vascular disease in obeisty

  1996cited by this paper

• The role of blood lipid and triglyceride‑glucose index in intracranial aneurysms: A retrospective study

  2025cites this paper
• Vegan and Plant-Based Diets in the Management of Metabolic Syndrome: A Narrative Review from Anti-Inflammatory and Antithrombotic Perspectives

  2025cites this paper
• Metabolic Syndrome and Atrial Cardiomyopathy on the Risk of Stroke Mortality in the General Population

  2025cites this paper
• Relationship between dietary flavan-3-ols intake and mortality in metabolic syndrome population; a large cohort study

  2025cites this paper
• Insulin resistance, metabolic syndrome and micro-RNA-122 serum level in patients with cerebral venous sinus thrombosis: a case-control study

  2024cites this paper
• Impact of the triglyceride-glucose index on 28-day mortality in non-diabetic critically Ill patients with sepsis: a retrospective cohort analysis

  2024cites this paper
• Unconventional localization of PAI-1 in PML bodies: A possible link with cellular growth of endothelial cells

  2024cites this paper
• Procoagulant factors and future risk of arterial cardiovascular disease in patients with prior venous thrombosis: A cohort study

  2023cites this paper
• Metabolic syndrome and ischaemic stroke in non-anticoagulated atrial fibrillation with low CHA2DS2-VASc scores

  2023cites this paper
• Association between Triglyceride-Glucose Index and Early Neurological Outcomes after Thrombolysis in Patients with Acute Ischemic Stroke

  2023cites this paper
• Facial Nerve Palsy in Hypertriglyceridemia-Induced Pancreatitis: A Case Report and Literature Review

  2023cites this paper
• Overexpression of Plg-RKT protects against adipose dysfunction and dysregulation of glucose homeostasis in diet-induced obese mice

  2023cites this paper
• Trends and Perspective of Metabolic Syndrome

  2022cites this paper
• Independent risk factors for an increased incidence of thromboembolism after lung transplantation

  2022cites this paper
• Association of the metabolic syndrome with PAI 1act and clot lysis time over a 10-year follow up in an African population.

  2022cites this paper
• Relationship between bullous pemphigoid and metabolic syndrome: a 12-year case–control study conducted in China

  2022cites this paper
• The potential role of insulin resistance in predicting outcome from intravenous thrombolytic therapy

  2022cites this paper
• Anticoagulants and antiaggregants in the COVID-19 era

  2021cites this paper
• The plasminogen receptor Plg‐RKT regulates adipose function and metabolic homeostasis

  2021cites this paper
• Physiologie et exploration de la fibrinolyse

  2021cites this paper
• Postoperative Pharmacologic Anticoagulation following Temporal Lobe Resection of a Gliosarcoma in a Hypercoagulable Patient

  2021cites this paper
• The effect of plant-based diets on thrombotic risk factors.

  2021cites this paper
• Role of Biomarkers as Prognostic Factors in Acute Peripheral Facial Palsy

  2021cites this paper
• High Triglyceride Glucose Index Is Associated with Poor Outcomes in Ischemic Stroke Patients after Reperfusion Therapy

  2021cites this paper
• Mechanism of Thrombus Formation in Regard to Diet

  2020cites this paper
• Use of the ZDF rat to model dietary fat induced hypercoagulability is limited by progressive and fatal nephropathy.

  2020cites this paper
• Fibrinolytics for the Treatment of Pulmonary Embolism.

  2020cites this paper
• Evaluation of Transcriptomic Regulations behind Metabolic Syndrome in Obese and Lean Subjects

  2020cites this paper
• Covid-19 and Metabolic Syndrome.

  2020cites this paper
• Pre-transplant portal vein thrombosis in non-alcoholic fatty liver disease patients-pathogenesis, risk factors, and implications on management.

  2020cites this paper
• Inflammation and thrombosis in COVID-19 pathophysiology: proteinase-activated and purinergic receptors as drivers and candidate therapeutic targets

  2020cites this paper
• An overview of the health benefits of Prunus species with special reference to metabolic syndrome risk factors.

  2020cites this paper
• Metabolic syndrome increases risk for perioperative outcomes following posterior lumbar interbody fusion

  2020cites this paper
• Relationship of Body Adiposity with Platelet Function in Obese and Non-obese Individuals

  2020cites this paper
• The Physiopathological Crossroads of Aging

  2019cites this paper
• Arterial Aging and Age-Associated Arterial Diseases

  2019cites this paper
• Perioperative management of patients with atrial fibrillation receiving anticoagulant therapy

  2019cites this paper
• Strain/Strain Rate Imaging of Impaired Left Atrial Function in Patients with Metabolic Syndrome

  2019cites this paper
• Whey Protein and the Metabolic Syndrome

  2019cites this paper
• Association of Patients' Characteristics with Acupuncture Treatment Outcomes in Treating Bell's Palsy: Results from a Randomised Controlled Trial

  2019cites this paper
• Dairy Whey Proteins and Obesity

  2019cites this paper
• Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus

  2018cites this paper
• COSMIC project: consensus on the objectives of the metabolic syndrome in clinic

  2018cites this paper
• Use of non‐vitamin K oral anticoagulants in people with atrial fibrillation and diabetes mellitus

  2018cites this paper
• The effect of metabolic syndrome on Bell’s palsy recovery rate

  2018cites this paper
• Homeostasis model assessment of insulin resistance in relation to the poor functional outcomes in nondiabetic patients with ischemic stroke

  2018cites this paper
• Effect of Sleeve Gastrectomy on Platelet Counts and Mean Platelet Volumes

  2018cites this paper
• Not all clots are created equal: a review of deficient thrombolysis with tissue plasminogen activator (tPA) in patients with metabolic syndrome

  2018cites this paper
• Assessment of Early Left Ventricular Diastolic Dysfunction in Patients with Metabolic Syndrome by 2D Speckle Tracking Echocardiography

  2018influential citation
• Increased adhesion molecule levels in systemic lupus erythematosus: relationships with severity of illness, autoimmunity, metabolic syndrome and cortisol levels

  2018cites this paper
• Insulin resistance and the metabolic syndrome

  2017cites this paper
• Implication of Free Fatty Acids in Thrombin Generation and Fibrinolysis in Vascular Inflammation in Zucker Rats and Evolution with Aging

  2017cites this paper
• The Role of Adipokines in the Pathophysiology of Cardiovascular Diseases

  2017cites this paper
• A low or high BMI is a risk factor for renal hematoma after extracorporeal shock wave lithotripsy for kidney stones

  2017cites this paper
• The prevalence of metabolic syndrome and its components among overweight and obese Nigerian adolescents and young adults

  2017cites this paper
• Vanishing Aortic Thrombus

  2017cites this paper
• Effects of resistin on platelet function and its receptor, adenylyl cyclase associated protein 1

  2017cites this paper
• Fibrinolysis inhibitors in plaque stability: a morphological association of PAI‐1 and TAFI in advanced carotid plaque

  2017cites this paper
• Development of a plasminogen activator inhibitor (PAI-1) assay and comparison of plasma PAI-1 activity in hyperlipidemic/dyslipidemic dogs with either hyperadrenocorticism or diabetes mellitus, and healthy dogs.

  2017cites this paper
• The Role of PAI-1 4G/5G Promoter Polymorphism and Its Levels in the Development of Ischemic Stroke in Young Indian Population

  2017cites this paper
• Effect of palm-based tocotrienols and tocopherol mixture supplementation on platelet aggregation in subjects with metabolic syndrome: a randomised controlled trial

  2017cites this paper
• Atrial Fibrillation, Type 2 Diabetes, and Non–Vitamin K Antagonist Oral Anticoagulants: A Review

  2017cites this paper
• Thrombin promotes diet-induced obesity through fibrin-driven inflammation

  2017cites this paper
• White Blood Cell Count to Mean Platelet Volume Ratio Is a Prognostic Factor in Patients with Non-ST Elevation Acute Coronary Syndrome with or without Metabolic Syndrome

  2016cites this paper
• Plasminogen activator inhibitor-1 in black South Africans, methodological and clinical considerations

  2016cites this paper
• Pathophysiology and management of hemostatic alterations in cirrhosis and liver transplantation

  2016cites this paper
• Platelet dependent thrombosis, blood thrombogenicity and response to antiplatelet therapy in health, ageing and type 2 diabetes mellitus

  2016cites this paper
• PATHOGENETIC MECHANISMS OF THROMBOEMBOLIC COMPLICATIONS OF THE METABOLIC SYNDROME IN PREGNANCY

  2016cites this paper
• THE STRUCTURE OF THE GENETIC POLYMORPHISMS IN PATIENTS WITH METABOLIC SYNDROME AND A COMPLICATED PREGNANCY IN HISTORY

  2016cites this paper
• Metabolic syndrome update.

  2016cites this paper
• Variable Resistance to Plasminogen Activator Initiated Fibrinolysis for Intermediate-Risk Pulmonary Embolism

  2016cites this paper
• Degree of obesity influences the relationship of PAI-1 with body fat distribution and metabolic variables in African women.

  2016cites this paper
• The contribution of different adipose tissue depots to plasma plasminogen activator inhibitor-1 (PAI-1) levels.

  2016cites this paper
• ANTITHROMBOTIC THERAPY IN PATIENTS WITH METABOLIC SYNDROME AFTER ABDOMINAL DELIVERY

  2016cites this paper
• Effects of restoring normoglycemia in type 1 diabetes on inflammatory profile and renal extracellular matrix structure after simultaneous pancreas and kidney transplantation.

  2015cites this paper
• Metabolic syndrome, platelet activation and the development of transient ischemic attack or thromboembolic stroke.

  2015influential citation
• The simultaneous occurrence of both hypercoagulability and hypofibrinolysis in blood and serum during systemic inflammation, and the roles of iron and fibrin(ogen).

  2015cites this paper
• Predisposing factors to post-operative adhesion development.

  2015cites this paper
• SERBP1 Is a Component of the Liver Receptor Homologue-1 Transcriptional Complex.

  2015cites this paper
• Metabolic syndrome, atrial fibrillation, and stroke: Tackling an emerging epidemic.

  2015cites this paper
• Metabolic Syndrome Predicts Refractoriness to Intravenous Thrombolysis in Acute Ischemic Stroke.

  2015cites this paper
• A study of changes in glucose metabolism and inflammatory markers in morbidly obese patients undergoing bariatric surgery

  2015cites this paper
• Thrombin stimulates insulin secretion via protease-activated receptor-3

  2015cites this paper
• UvA-DARE ( Digital Academic Repository ) Factor XI as target for antithrombotic therapy

  2014cites this paper
• Inflammation and atherosclerosis

  2014cites this paper
• The influence of apolipoprotein A5 T-1131C and apolipoprotein E common genetic variants on the levels of hemostatic markers in dyslipidemic patients.

  2014cites this paper
• Bariatric Surgery Decreases Monocyte-Platelet Aggregates in Blood: a Pilot Study

  2014cites this paper
• A Genetic Screening Test for Obesity Based on Stochastic Sensing

  2014cites this paper
• Fibrinolytic factors in relation to anthropometry and incident type 2 diabetes.

  2014cites this paper
• Role of nitric oxide in septal coronary arteries of obese Zucker rats

  2014cites this paper
• Association between Vitamin D Status and Risk of Metabolic Syndrome among Korean Postmenopausal Women

  2014cites this paper
• Determination and comparison of how the chain number and chain length of a lipid affects its interactions with a phospholipid at an air/water interface.

  2014cites this paper
• Platelet thromboxane (11-dehydro-Thromboxane B2) and aspirin response in patients with diabetes and coronary artery disease.

  2014cites this paper
• Human tissue-type plasminogen activator

  2014cites this paper
• Psoriasis and atherosclerosis: Is there a need for novel biomarkers assessing cardiovascular risk?

  2014cites this paper
• Zucker Diabetic Fatty rats exhibit hypercoagulability and accelerated thrombus formation in the Arterio-Venous shunt model of thrombosis.

  2014cites this paper
• Hemostatic factors and the metabolic syndrome.

  2014cites this paper
• Status of coagulation and Platelet Hemostasis parameters in patients with permanent atrial fibrillation on the background of metabolic syndrome

  2014influential citation
• Impact of metabolic syndrome on perioperative complication rates after total joint arthroplasty surgery.

  2014cites this paper
• La metformina nell'obesità associata alla sindrome metabolica Razionale per l'uso della formulazione slow release

  2014cites this paper